Search →

Overview

Investing In a Better Future

If you’ve come to this page, we hope you are as excited about Bicycle as we are. Our goal is to be one of the world’s leading solid tumor therapeutics companies. Please give us a call or send us an email if you have questions about our science, clinical programs, strategy or any other aspect of the Bicycle story.
Press
Date
Title
Date
09/11/23
Title
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
Date
09/05/23
Title
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Date
08/03/23
Title
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Date
07/18/23
Title
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Overview →Stock Information →SEC Filings →UK Annual Reports →Governance + Leadership →Presentation + Events →Analyst Coverage →Press Releases →Investor Resources →

Search